Recent Articles

December 2, 2014 9:52 am
Stephanie Guzowski, Editor
If you could take a blood test that could detect — with nearly 100% accuracy — whether you were genetically destined to get Alzheimer’s disease, would you take that test? Read more...
November 28, 2014 9:55 am
Cynthia Fox, Science Editor
Ian Wilmut, father of the cloned Dolly the Sheep, is now proposing to father a global induced pluripotent stem (iPS) cell handbook— to go with a proposed new global network of iPS cell haplobanks. Read more...                                   
November 26, 2014 12:00 pm
Ryan Bushey, Associate Editor
Concerns have been raised relating to a lucrative investment the Cystic Fibrosis Foundation made in a biotechnology company. Read more...                    
November 25, 2014 8:55 am
Cynthia Fox, Science Editor
Guided by breakthrough research on the Estrogen Receptor 1 (ESR1) gene, many researchers and pharmaceutical companies are in hot pursuit of the next big anti-resistance breast cancer drug. Read more...                 
November 24, 2014 2:22 pm
Ryan Bushey, Associate Editor
The researchers feel that the current policies for pharmaceutical marketing need to be updated as soon as possible. Read more...                      
November 21, 2014 8:48 am
Drug Discovery & Development Staff
Beta blockers offer no survival advantages to patients, post-heart attack, but they do improve survival among some heart failure patients. Read more...                                                          
November 20, 2014 9:42 am
Cynthia Fox, Science Editor
People with mental health problems are “significantly” more likely to have stroke or heart disease, according to a study unveiled at a recent Canadian Cardiovascular Congress. Read more...
November 19, 2014 11:29 am
Guizhong Liu, Senior Director of Cancer Biology, Crown Bioscience Inc.
Drug discovery is a protracted and uncertain process that needs to overcome many hurdles during preclinical and clinical development before it finally achieves regulatory approval for patient treatment. For every drug that reaches the marketplace, well over 100 have been abandoned at some point in their development. Read more...
November 18, 2014 9:52 am
Drug Discovery & Development Staff
In honor of the SCI’s 50th anniversary, the journal Nature asked Thomson Reuters for the 100 most highly cited papers of all time.  Read more...                                  
November 18, 2014 10:56 am
Christina Jakubowski, Managing Editor, Bioscience Technology
More than 30,000 brain advocates from academia, industry and media converged on Washington, D.C. this week for the 44th annual meeting of the Society for Neuroscience (SfN). Read more...
Subscribe to Drug Discovery & Development